Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Non-cash Items (2016 - 2017)

BeOne Medicines (BEIGF) has disclosed Non-cash Items for 2 consecutive years, with $1.5 million as the latest value for Q4 2017.

  • Quarterly Non-cash Items fell 97.33% to $1.5 million in Q4 2017 from the year-ago period, while the trailing twelve-month figure was $1.5 million through Dec 2017, down 97.33% year-over-year, with the annual reading at $1.5 million for FY2017, 97.33% down from the prior year.
  • Non-cash Items for Q4 2017 was $1.5 million at BeOne Medicines, down from $54.9 million in the prior quarter.
  • The five-year high for Non-cash Items was $54.9 million in Q4 2016, with the low at $1.5 million in Q4 2017.